Literature DB >> 15855575

Elevated pregnancy losses at high and low extremes of maternal glucose in early normal and diabetic pregnancy: evidence for a protective adaptation in diabetes.

Lois Jovanovic1, Robert H Knopp, Haesook Kim, William T Cefalu, Xiao-Dong Zhu, Young Jack Lee, Joe Leigh Simpson, James L Mills.   

Abstract

OBJECTIVE: Early pregnancy losses increase with marked hyperglycemia in diabetic pregnancy. However, mean loss rates do not differ from those of nondiabetic pregnancy. This observation might be explained by increased fetal losses at the extremes of glycemia in diabetic and nondiabetic pregnancy. To test this hypothesis, we examined relationships of proximate measures of prior glycemia, glycated protein and fructosamine, to pregnancy loss. RESEARCH DESIGN AND METHODS: A total of 389 diabetic and 429 nondiabetic pregnant subjects participated in the Diabetes In Early Pregnancy study. Glycated protein and fructosamine measurements were standardized as multiples of control values for each center (Z score). The logarithm of odds of pregnancy loss were plotted against Z scores and tested by logistic models.
RESULTS: Mean pregnancy loss rates were 12% in diabetic and 13% in normal pregnancies. However, over six intervals of glycated protein in diabetic pregnancy, fetal loss rates at the upper and lower extremes (24 and 33%, respectively) were approximately threefold higher than the four intervening rates (8-14%). The odds ratio of pregnancy loss for these extreme intervals to the intervening intervals is 3.0 (P = 0.01). Nondiabetic losses showed a similar pattern. In confirmation, logit pregnancy losses were increased in a J-shaped curve at the glycemic extremes in normal (P < 0.019) and diabetic (P < 0.015) pregnancy. The upper glycemic extreme in diabetic pregnancy was two- to fivefold higher than in control pregnancy.
CONCLUSIONS: Pregnancy losses are increased at the extremes of glycemia in both normal and diabetic pregnancy but at higher levels in diabetic pregnancy. The data suggest defensive adaptations against hyperglycemia in diabetic pregnancy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15855575     DOI: 10.2337/diacare.28.5.1113

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  19 in total

Review 1.  [Endocrine emergencies during pregnancy].

Authors:  B Harbeck; M Schütt; F Sayk
Journal:  Med Klin Intensivmed Notfmed       Date:  2012-02-02       Impact factor: 0.840

2.  Pregnancy, birth, and infant outcomes by maternal fertility status: the Massachusetts Outcomes Study of Assisted Reproductive Technology.

Authors:  Barbara Luke; Daksha Gopal; Howard Cabral; Judy E Stern; Hafsatou Diop
Journal:  Am J Obstet Gynecol       Date:  2017-04-08       Impact factor: 8.661

Review 3.  The vicious cycle of diabetes and pregnancy.

Authors:  David J Pettitt; Lois Jovanovic
Journal:  Curr Diab Rep       Date:  2007-08       Impact factor: 4.810

4.  Managing preexisting diabetes for pregnancy: summary of evidence and consensus recommendations for care.

Authors:  John L Kitzmiller; Jennifer M Block; Florence M Brown; Patrick M Catalano; Deborah L Conway; Donald R Coustan; Erica P Gunderson; William H Herman; Lisa D Hoffman; Maribeth Inturrisi; Lois B Jovanovic; Siri I Kjos; Robert H Knopp; Martin N Montoro; Edward S Ogata; Pathmaja Paramsothy; Diane M Reader; Barak M Rosenn; Alyce M Thomas; M Sue Kirkman
Journal:  Diabetes Care       Date:  2008-05       Impact factor: 19.112

5.  Gestational carrier BMI and reproductive, fetal and neonatal outcomes: are the risks the same with increasing obesity?

Authors:  K Coyne; L D Whigham; K O'Leary; J K Yaklic; R A Maxwell; S R Lindheim
Journal:  Int J Obes (Lond)       Date:  2015-08-20       Impact factor: 5.095

6.  Trends and racial and ethnic disparities in the prevalence of pregestational type 1 and type 2 diabetes in Northern California: 1996-2014.

Authors:  Tiffany Y Peng; Samantha F Ehrlich; Yvonne Crites; John L Kitzmiller; Michael W Kuzniewicz; Monique M Hedderson; Assiamira Ferrara
Journal:  Am J Obstet Gynecol       Date:  2016-10-15       Impact factor: 8.661

7.  Dysglycemias in pregnancy: from diagnosis to treatment. Brazilian consensus statement.

Authors:  Carlos Antonio Negrato; Renan M Montenegro; Rosiane Mattar; Lenita Zajdenverg; Rossana P V Francisco; Belmiro Gonçalves Pereira; Mauro Sancovski; Maria Regina Torloni; Sergio A Dib; Celeste E Viggiano; Airton Golbert; Elaine C D Moisés; Maria Isabel Favaro; Iracema M P Calderon; Sonia Fusaro; Valeria D D Piliakas; José Petronio L Dias; Marilia B Gomes; Lois Jovanovic
Journal:  Diabetol Metab Syndr       Date:  2010-04-24       Impact factor: 3.320

8.  Pre-pregnancy care and pregnancy outcomes in type 1 diabetes mellitus: a comparison of continuous subcutaneous insulin infusion and multiple daily injection therapy.

Authors:  K J Neff; R Forde; C Gavin; M M Byrne; R G R Firth; S Daly; F M McAuliffe; M Foley; M Coffey; S Coulter-Smith; B T Kinsley
Journal:  Ir J Med Sci       Date:  2013-10-22       Impact factor: 1.568

9.  Adherence to medication for chronic disorders during pregnancy: results from a multinational study.

Authors:  Angela Lupattelli; Olav Spigset; Hedvig Nordeng
Journal:  Int J Clin Pharm       Date:  2013-10-27

10.  Maternal diabetes alters transcriptional programs in the developing embryo.

Authors:  Gabriela Pavlinkova; J Michael Salbaum; Claudia Kappen
Journal:  BMC Genomics       Date:  2009-06-18       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.